Moreover, our assessment found that TNBC patients possessed increased levels of TGFBRA mRNA expression and reduced disease-free survival compared to other breast cancer subtypes, as well as highlighting the importance of TGF-β modulation for prospective treatment [171]. This evidence concerns the gene TGFB1 and breast cancer.